Constitutive RET tyrosine kinase activation in hereditary medullary thyroid cancer: clinical opportunities

Area of Science:

• Oncology
• Genetics
• Endocrinology

Background:

• Hereditary medullary thyroid cancer (MTC) management relies on understanding genotype-phenotype correlations.
• Early prophylactic thyroidectomy is crucial for preventing MTC in individuals with germline REarranged during Transfection (RET) mutations.

Purpose of the Study:

• To detail the timing of prophylactic thyroidectomy based on specific RET mutation types and their activation mechanisms.
• To inform targeted therapy development for RET mutation carriers.

Main Methods:

• Analysis of genotype-phenotype relationships in hereditary MTC.
• Correlation of RET mutation profiles with recommended prophylactic thyroidectomy timelines.
• Evaluation of preoperative calcitonin levels for lymph node dissection decisions.

Main Results:

• Prophylactic thyroidectomy timing is stratified by RET mutation risk: highest-risk at 6 months, high-risk before 5 years, and least-high-risk before 5-10 years.
• Lymph node dissection may be unnecessary if preoperative calcitonin levels are not elevated.
• Detailed molecular insights refine the therapeutic window for MTC management.

Conclusions:

• Genomic information significantly refines prophylactic thyroidectomy timing in hereditary MTC.
• Personalized surgical approaches based on RET mutation status improve patient outcomes.
• Further understanding of RET function is key to developing novel targeted therapies for unresectable or missed MTC cases.